CLDX Celldex Therapeutics, Inc.

2d ago, source: Seeking Alpha

Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include ...

Which Is a Better Investment, Celldex Therapeutics, Inc. or BIO-TECHNE Corp Stock?

5d ago, source: American Association of Individual Investors

Learn more about whether Celldex Therapeutics, Inc. or BIO-TECHNE Corp is a better investment based on AAII's A+ Investor ...

Celldex Hails Enrolment News, Shares Poke Ahead

7d ago, source:

GXO Joins with Daikin <li /> U.S. Bancorp Slides on Q1 Earnings <li /> Albemarle Hikes on Donation News <li /> Now What?

Celldex Therapeutics Announces Pricing of Upsized $400 Million Public Offering of Common Stock

1mon ago, source: Nasdaq

HAMPTON, N.J., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (“Celldex” or the “Company”) (Nasdaq: CLDX) today announced the pricing of an ...

Celldex Announces Completion of Enrollment in Phase 2 Study of Barzolvolimab in Patients with Chronic Inducible Urticaria

7d ago, source:

"We are very grateful to all the investigators and patients who supported this trial," said Anthony Marucci, President and Chief Executive Officer of Celldex Therapeutics. "While individuals with ...

Celldex Therapeutics Inc CLDX

3d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Celldex Therapeutics Inc CLDX

6d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Celldex Therapeutics, Inc. (CLDX)

1mon ago, source: Yahoo Finance

Overall score is calculated based on proprietary scores based on sector averages in key company indicators: fair value, dividends, innovation, hiring, and insider sentiment. Note: if you don't see ...

Celldex Therapeutics Inc.

28d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...